Position in ENTX
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$13,320
-$15,780 QoQ
Shares Held
12,000
-20.0% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ENTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in ENTX
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $13,320 | 12,000 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $29,100 | 15,000 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $40,320 | 21,000 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $44,517 | 23,430 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $52,677 | 30,987 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $17,871 | 8,430 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $16,017 | 8,430 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $5,520 | 3,000 | Shares | Defined | 2024-08-14 | |
| 2021-12-31 | $39,032 | 13,866 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $76,173 | 16,173 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||